biotech · Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma · CUE
Cue Biopharma
Cue Biopharma is a biotech organization headquartered in Boston, USA. It trades on NYSE under ticker CUE. Primary therapeutic focus areas include Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2014
- Employees
- 37
- Programs
- 5
- Drugs
- 0
- Patents
- 30
Quick answer
Cue Biopharma is a biotech organization headquartered in Boston, USA. It trades on NYSE under ticker CUE. Primary therapeutic focus areas include Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Colorectal Cancer, Recurrent Glioblastoma. NovaPharmaNews links 5 clinical program(s), 0 drug profile(s), and 30 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (3), phase 2 (2).
Company snapshot
Cue Biopharma, a clinical-stage biopharmaceutical company is developing a novel class of therapeutic biologics to selectively engage and modulate disease-relevant T cells for the treatment of autoimmune disease. Cue Biopharma’s proprietary platform, Immuno-STAT® (Selective Targeting and Alteration of T Cells) and biologics are designed to harness the curative potential of the body’s innate immune
- 5 active pipeline program(s) linked via ClinicalTrials.gov.
- 30 US patent(s) indexed to this assignee profile.
- 5 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Cue Biopharma. Not investment advice.
Top assets
Momentum
Proprietary activity score for Cue Biopharma.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for Cue Biopharma.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Cue Biopharma?
-
Is Cue Biopharma publicly traded?
-
What drugs does Cue Biopharma develop or market?
-
What are the latest developments for Cue Biopharma?
-
What therapeutic areas does Cue Biopharma focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.